A new report highlights the number of Americans who are candidates for reducing their risk of heart and vascular disease because they have elevated LDL levels. It also reveals how many of them are actually taking lipid-lowering drugs, such as statins. And as it turns out, it's not enough.
Walnuts seem to be making their way into the news with increasing frequency. A recent study found that walnuts significantly aided diet quality, while helping the lining of the walls of blood vessels and improving total and LDL ("bad") cholesterol levels.
A new study published in the European Journal of Clinical Nutrition found that eating at a full-service restaurant is no better for your health than eating at a fast food joint. In fact, in some cases, a full-service restaurant is less healthy.
In 2013, a combined panel of cardiology and lipid experts under the aegis of the American College of Cardiology and the American Heart Association (ACC/AHA) published revised recommendations for candidates for statin therapy to reduce the risk of cardiovascular events (heart attack, stroke or sudden death due to coronary artery disease: CVD). Rather than focusing, as always before (e.g. the ATP-III published in 2003) on lipid levels, LDL especially, the new report emphasized overall heart risk using other parameters including age, weight, blood pressure, and diabete
A new series of articles by the NYTimes Gina Kolata focuses on improvements in dealing with emergency cardiac events, and indeed the progress has been remarkable. But that s not the solution to reducing the toll of our nation s leading killer: coronary disease.
Anyone who has been paying attention recognizes that governmental dietary advice seems to change pretty often.
Follow-up on two of our recent, important Dispatch items. California s Assembly has cleared the next-to-last legislative hurdle toward removing the state s non-medical exemptions for children s vaccinations. And an FDA panel has approved overwhelmingly a new type of cholesterol-lowering medication.
But now, an immune-based approach that is completely different from the statin mode of action, may be an alternative way to prevent cardiovascular events. Not by inhibiting the production of cholesterol, but by preventing the release of LDL cholesterol the real culprit. This could end up being superior to the mode of action by which statins function.
The latest in health news: The myths on high protein diets, Glyphosate ruling ignores the science, & Dr. Ross' latest op-ed on Science 2.0.
As reported by Ed Mr. Pharmaceuticals Silverman, in yesterday s Wall Street Journal, there may be a new paradigm for significantly lowering LDL (bad) cholesterol, and reducing heart disease.
If you re one of those folks who complain that official nutrition advice is always changing, you d best sit down to read this because dietary cholesterol is no longer the villain we thought it was,
The cardiovascular benefit of the cholesterol-lowering statin drugs has been firmly established for quite some time. But, a twenty-year follow up of the West of Scotland Coronary Prevention Study (WOSCOPS) may have raised a few eyebrows. These drugs work better than expected even long after they have been stopped.